BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36476597)

  • 1. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
    Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
    BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Common Malignant Tumors in the Reproductive System of Chinese Women: Disease Burden During 1990-2019 and Prediction of Future Trend].
    Zheng N; Tang J; Ren XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):25-32. PubMed ID: 38433627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Years of life lost due to premature death and their trends in people with malignant neoplasm of female genital organs in Shanghai, China during 1995-2018: a population based study.
    Luo Z; He Y; Ma G; Deng Y; Chen Y; Zhou Y; Xu X; Li X; Du Y
    BMC Public Health; 2020 Oct; 20(1):1489. PubMed ID: 33004024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021.
    Qin Y; Tang C; Li J; Gong J
    BMC Cancer; 2024 May; 24(1):594. PubMed ID: 38750424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend of nasopharyngeal carcinoma mortality and years of life lost in China and its provinces from 2005 to 2020.
    Long Z; Wang W; Liu W; Wang F; Meng S; Liu J; Liu Y; Qi J; Wang L; Zhou M; Yin P
    Int J Cancer; 2022 Sep; 151(5):684-691. PubMed ID: 35285029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.
    Wang Z; Guo E; Yang B; Xiao R; Lu F; You L; Chen G
    Gynecol Oncol; 2021 Nov; 163(2):358-363. PubMed ID: 34507827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on long-term trends of cervical cancer mortality and years of life lost in Tianjin, 1999-2015].
    Zheng WL; Zhang H; Wang DZ; Zhang S; Pang S; Li CK; Jiang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jan; 40(1):64-69. PubMed ID: 30669733
    [No Abstract]   [Full Text] [Related]  

  • 8. The mortalities of female-specific cancers in China and other countries with distinct socioeconomic statuses: A longitudinal study.
    Jiang D; Niu Z; Tan X; He H; Ren L; Shen J; Zhu X; Zhao P; Liu M; Chen H; Wang R; Li Q; Cao G
    J Adv Res; 2023 Jul; 49():127-139. PubMed ID: 36130684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system.
    Xu Y; Liu W; Long Z; Wang L; Zhou M; Yin P
    BMC Cancer; 2023 Sep; 23(1):893. PubMed ID: 37735368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secular Trends of Liver Cancer Mortality and Years of Life Lost in Wuhan, China 2010-2019.
    Zhao Y; Yang D; Yan Y; Zhang X; Yang N; Guo Y; Yu C
    Curr Oncol; 2023 Jan; 30(1):938-948. PubMed ID: 36661720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model.
    Wang J; Lv H; Xue Z; Wang L; Bai Z
    Biomed Res Int; 2018; 2018():5307459. PubMed ID: 29750160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Changes in the Premature Death Rate in Lung Cancer in a Developed Region of China: Population-based Study.
    Ye W; Lu W; Li X; Chen Y; Wang L; Zeng G; Xu C; Ji C; Cai Y; Yang L; Luo Z
    JMIR Public Health Surveill; 2022 Apr; 8(4):e33633. PubMed ID: 35442209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
    Su SY
    Prev Med; 2023 Jul; 172():107551. PubMed ID: 37211252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's cancers in China: a spatio-temporal epidemiology analysis.
    He R; Zhu B; Liu J; Zhang N; Zhang WH; Mao Y
    BMC Womens Health; 2021 Mar; 21(1):116. PubMed ID: 33743648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
    Medhin LB; Tekle LA; Achila OO; Said S
    Sci Rep; 2020 Jun; 10(1):9099. PubMed ID: 32499531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034.
    Li S; Huang M; Zhu Y; Zeng H; Zhang F
    Eur J Cancer Prev; 2024 May; 33(3):252-261. PubMed ID: 37997908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990-2019.
    Azangou-Khyavy M; Ghasemi E; Rezaei N; Khanali J; Kolahi AA; Malekpour MR; Heidari-Foroozan M; Nasserinejad M; Mohammadi E; Abbasi-Kangevari M; Ghamari SH; Ebrahimi N; Koolaji S; Khosravifar M; Fateh SM; Larijani B; Farzadfar F
    BMC Womens Health; 2024 Jan; 24(1):69. PubMed ID: 38273304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
    Stojanovic MM; Rancic NK; Andjelković Apostolović MR; Ignjatović AM; Stojanovic DR; Mitic Lakusic VR; Ilic MV
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208629
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in Cause-Specific Injury Mortality in China in 2005-2019: Longitudinal Observational Study.
    Ji Z; Wu H; Zhu R; Wang L; Wang Y; Zhang L
    JMIR Public Health Surveill; 2023 Sep; 9():e47902. PubMed ID: 37713250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
    Liu Y; Shi W; Mubarik S; Wang F
    BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.